Caleres Comps May Improve In Q3 2025, But I Fear Margins, The Price Is Fair

Caleres (CAL) reported Q2 '25 results featuring a continued sales decline of 3.6%, albeit a sequential improvement from Q1, alongside a significant 60-80% collapse in adjusted/unadjusted earnings due to substantial margin erosion, including a 210bps drop in gross profit. The company also finalized its $110 million acquisition of Stuart Weitzman, increasing net debt. While the increased debt is deemed manageable, future margin pressure is anticipated from tariffs and integration costs. CAL currently trades at an approximate 8x forward earnings multiple based on optimistic assumptions, leading to a 'Hold' rating despite the challenging outlook.

Analysis

Caleres, Inc. (CAL) delivered a mixed Q2 '25 report, highlighted by a continued, albeit decelerating, sales decline and a severe collapse in profitability. Revenue decreased 3.6%, an improvement from the 7% drop in the prior quarter, with management signaling a potential return to flat or low-single-digit growth in Q3 based on positive 1% comparable sales in August. However, this top-line stabilization is overshadowed by significant margin erosion. Gross profit margin fell 210 basis points due to higher markdowns or costs, and operating deleverage contributed to a 60% decline in adjusted earnings. The company also finalized its $110 million acquisition of Stuart Weitzman, increasing net debt to approximately $306 million. While the debt is considered manageable under a newly expanded credit facility, future margins face pressure from potential tariffs and integration expenses. Based on optimistic assumptions of flat revenue and stable margins, the stock trades at an 8x forward earnings multiple, a valuation deemed fair but not compelling given the persistent operational challenges and macroeconomic headwinds.

Key Decisions for Investors

• Investors should treat the current 8x forward P/E multiple with caution, as it relies on optimistic assumptions of revenue stabilization and margin maintenance that run contrary to recent performance trends.
• The primary catalyst to monitor is the upcoming Q3 report for confirmation of the positive August sales trend; failure to sustain this modest recovery could trigger a negative re-rating of the stock.
• Given the increased balance sheet leverage from the Stuart Weitzman acquisition and significant near-term margin pressures, it is prudent to assess management's ability to integrate the new brand and control costs before increasing exposure.